A Case of Metastatic Melanoma Post Orthotopic Liver Transplantation

TL;DR

A case study shows that a liver transplant patient developed aggressive melanoma, highlighting the need for improved screening and understanding of post-transplant risks.

Contribution

This case report emphasizes the need for modified screening protocols to detect post-transplant melanoma earlier.

Findings

A 54-year-old liver transplant patient developed rapidly progressive metastatic melanoma.

Despite regular screening and treatment, the disease was fatal, suggesting a need for improved early detection methods.

Post-transplant immunosuppressive therapy may contribute to aggressive melanoma development.

Abstract

With the rising prevalence of organ transplantation, clinicians must be aware of the many potential complications that may arise. One such complication is post-transplantation melanoma. Herein, we present a case of advanced metastatic melanoma following orthotopic liver transplantation (OLT).

This is a 54-year-old cirrhotic male who underwent OLT that was complicated by metastatic melanoma. Despite adherence to yearly screening guidelines and timely radiation and immunotherapy, the disease course was rapidly progressive and fatal. This case aims to highlight the risk of post-transplantation melanoma and the potential need for screening modifications to identify melanoma earlier in its development.

The association between organ transplantation and melanoma is well-reported, but the underlying risks and mechanisms remain incompletely understood. One potential risk factor is post-transplant immunosuppressive therapy, which may result in fatally aggressive melanoma. Understanding the potential mortality risks in transplant patients, modifications to peri-transplant screening guidelines, and immunosuppressive therapy may be lifesaving.

Figures